The global scaffold technology market size is set to outnumber USD 1,484.8 million by 2026 growing at a CAGR of 10.38% during forecast period according to a new study published by Report Ocean. The report ‘Scaffold Technology Market Size, Share, Trends and Industry Analysis Report, By Product Type (Polymeric, Hydrogels, Micropatterned surface Microplates, Freeze Embryo Testing and Nanofiber- based); By Application; By End-use and By Regions: Segment Forecast 2019-2026’ provides an in-depth analysis of present market dynamics and envisioned future trends.
The global scaffold technology tissue engineering is registering high growth due to the rising number of minimally invasive surgeries for treating an increasing number of cancer patients across the globe. Increasing investments from Government and regional bodies also attract market growth without compromising on R&D facilities in use of this technology.
Factors favoring scaffold technology market are an inherent bias towards regenerative technology coupled with a rising number of organ transplant cases to repair the damaged tissue or organs during the forecast period. Scaffolds are very much needed in treatment of damaged or lifeless organs to support implants that are operated into patients’ body. The market is rather upbeat because of the use of technology. Rise in geriatric population causing organ failure which should be treated soon, causing an area of research using 3D Cell with application, collates further market growth.
Resorbable scaffold technology is divided based upon product type, application and end-use. The product type is further sub-divided into polymeric scaffolds, hydrogels, micropatterned surface microplates, freeze embryo testing and nano fiber-based scaffolds. Considering end-use, research laboratories and institutes, biotechnology and pharmaceutical organizations, hospital and diagnostic centers take dominant market position.
Scaffold technologies are fundamentally tissue engineering that seamlessly enter biological substitutes with applications for regenerative tissue repair or organ repair. Product type includes cell attachments and migration, nutrients and product diffusion.
Hydrogel based scaffolds were very popular in use with abundant availability and round- the- clock development. Their unilateral acceptance in cartilage tissue scaffolds that helps growth of cells and drug delivery is attributed to their adoption.
By geography, scaffold technology is segmented into five major regions namely North America, Europe, Asia pacific, Latin America and Middle East and Africa. North America leads the market due to high prevalence of cancer in the region taking a huge death toll. According to global estimates by WHO, cancer is the leading cause of death accounting for 9.6 million deaths in 2018 that will further drive market growth. Copious investments by Government in R&D facilities to nurture this technology will profusely support market growth.
Asia pacific will display high growth owing to Government investments in development of healthcare infrastructure and controlled policies in promoting use of this technology. Increasing prevalence of cancer in Asia pacific and increasing awareness for adoption of organ transplant will also add impetus to the market. Rising number of smoking populace and alcohol abuse due to lifestyle changes has powered Asia pacific market.
Key findings in the scaffold technology market indicate rapid strides by companies in technology pursuits. Companies leverage factors such as increasing awareness in treating abundance of chronic diseases and also awareness of organ transplant in developing countries, in an endeavor to bring new and advanced technologies to the fore.
The key players in scaffold technology market include Merck and Company, Thermo Fischer Scientific INc., 3D Biotec LLC, Pelo Biotec GmbH, Corning Inc., Avacta Life Sciences Limited, Nanofiber Solutions, Nuvasive, Inc., Tecan Trading AG and Molecular Matrix Inc. among others.
Report Ocean has segmented the global scaffold technology market on the basis of product type, application, end-use and region.
Scaffold Technology Product type Outlook (Revenue USD Millions 2015-2026)
Micropatterned surface microplates
Freeze embryo testing
Nano fiber-based scaffolds
Scaffold Technology Application Outlook (Revenue USD Millions 2015-2026)
Stem cell research
Tissue engineering and clinical application
Scaffold Technology End-use Outlook (Revenue USD Millions 2015-2026)
Research Laboratories and Institutes
Biotechnology and Pharmaceutical Organizations
Hospitals and Diagnosis Centers
Scaffold Technology Regional Outlook (Revenue USD Millions 2015-2026)
Middle East and Africa